Results 231 to 240 of about 46,834 (302)
Development and Preliminary Testing of the Healthy Transition Scale for Patients Undergoing Haemodialysis. [PDF]
Chang AK +4 more
europepmc +1 more source
Endotoxins and Biological Implications—Review
Graphical overview of endotoxin sources, exposure routes, biological effects, detection methods, and routes of elimination. ABSTRACT Endotoxins, also known as lipopolysaccharides (LPSs), are structural components of the outer membrane of Gram‐negative bacteria and some cyanobacteria.
Uzair Ishtiaq +5 more
wiley +1 more source
Reusing Haemodialysis Reverse Osmosis Reject Water: A Case Report From a Sydney Metropolitan Hospital, Australia. [PDF]
Hsu WY +6 more
europepmc +1 more source
ABSTRACT Cutaneous oxalosis is an uncommon manifestation of primary hyperoxalosis, which can often resemble other cutaneous manifestations of end stage renal disease (ESRD), particularly calciphylaxis. We report the case of a 46 year old female with primary hyperoxaluria type one (PH1) believed to be well‐controlled on lumasiran, a small interfering ...
Shrina Patel +3 more
wiley +1 more source
Feet in Peril: Assessment of Feet in Patients Undergoing Haemodialysis. [PDF]
Ünal A +4 more
europepmc +1 more source
ABSTRACT Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an ...
Ann S. Forrest +3 more
wiley +1 more source
Right Ventricular Pseudoaneurysm in a Chronic Haemodialysis Patient: A Common Presentation of Shortness of Breath With a Rare Cause. [PDF]
Mohammed EP +4 more
europepmc +1 more source
Use of Glucose‐Lowering Drugs for Type 2 Diabetes Among Danish Care Home Residents
ABSTRACT Aims Care home admission often reflects frailty and limited life expectancy, potentially altering the benefit‐harm balance of glucose‐lowering drug (GLD) treatment for type 2 diabetes (T2D). Real‐world data on treatment patterns in this setting remain limited. We examined GLD use for T2D among Danish care home residents.
Hanin Harbi +7 more
wiley +1 more source
The Impact of Educational or Behavioural Interventions on Fatigue in Adults Receiving Haemodialysis: A Systematic Review and Meta-Analysis. [PDF]
Zhang Q, Gong T, Ye Y.
europepmc +1 more source

